Gene · 8784
Papers4,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 4,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| T cells in health and disease. | Signal Transduct Target Ther | 2023 | 37332039 | PubTator, text mining | PubMed |
First-in-Human, Phase I Dose-Escalation and Dose-Expansion Study of Trophoblast Cell-Surface Antigen 2-Directed Antibody-Drug Conjugate Datopotamab Deruxtecan in Non-Small-Cell Lung Cancer: TROPION-PanTumor01. | J Clin Oncol | 2023 | 37327461 | PubTator, text mining | PubMed |
| A unique expression pattern of LAG3 distinct from that of other immune checkpoints in diffuse large B-cell lymphoma. | Cancer Med | 2023 | 37326144 | PubTator, text mining | PubMed |
| FANCI is Associated with Poor Prognosis and Immune Infiltration in Liver Hepatocellular Carcinoma. | Int J Med Sci | 2023 | 37324186 | PubTator, text mining | PubMed |
| T cell receptor and B cell receptor exhibit unique signatures in tumor and adjacent non-tumor tissues of hepatocellular carcinoma. | Front Immunol | 2023 | 37313417 | PubTator, text mining | PubMed |
| Multidimensional analysis of immune cells from COVID-19 patients identified cell subsets associated with the severity at hospital admission. | PLoS Pathog | 2023 | 37311004 | PubTator, text mining | PubMed |
| Engineered soluble, trimerized 4-1BBL variants as potent immunomodulatory agents. | Cancer Immunol Immunother | 2023 | 37310433 | PubTator, text mining | PubMed |
| Harnessing type I interferon-mediated immunity to target malignant brain tumors. | Front Immunol | 2023 | 37304294 | PubTator, text mining | PubMed |
| A Panorama of Immune Fighters Armored with CARs in Acute Myeloid Leukemia. | Cancers (Basel) | 2023 | 37297016 | PubTator, text mining | PubMed |
| Monitoring islet specific immune responses in type 1 diabetes clinical immunotherapy trials. | Front Immunol | 2023 | 37283770 | PubTator, text mining | PubMed |
| The role of regulatory T cells and follicular T helper cells in HBV infection. | Front Immunol | 2023 | 37275865 | PubTator, text mining | PubMed |
| Barriers to overcoming immunotherapy resistance in glioblastoma. | Front Med (Lausanne) | 2023 | 37275361 | PubTator, text mining | PubMed |
| MMP14 is a diagnostic gene of intrahepatic cholangiocarcinoma associated with immune cell infiltration. | World J Gastroenterol | 2023 | 37274806 | PubTator, text mining | PubMed |
| Knocking down NSUN5 inhibits the development of clear cell renal cell carcinoma by inhibiting the p53 pathway. | Aging (Albany NY) | 2023 | 37263638 | PubTator, text mining | PubMed |
| Granulocyte-Macrophage Colony-Stimulating Factor Influence on Soluble and Membrane-Bound ICOS in Combination with Immune Checkpoint Blockade. | Cancer Immunol Res | 2023 | 37262321 | PubTator, text mining | PubMed |
| TMIGD2 as a potential therapeutic target in glioma patients. | Front Immunol | 2023 | 37261362 | PubTator, text mining | PubMed |
| Risk prediction for dermatomyositis-associated hepatocellular carcinoma. | BMC Bioinformatics | 2023 | 37259059 | PubTator, text mining | PubMed |
| The joint role of methylation and immune-related lncRNAs in ovarian cancer: Defining molecular subtypes and developing prognostic signature. | Transl Oncol | 2023 | 37257331 | PubTator, text mining | PubMed |
| Current immune therapeutic strategies in advanced or metastatic non-small cell lung cancer. | Chin Med J (Engl) | 2023 | 37257112 | PubTator, text mining | PubMed |
| Targeted TLR9 Agonist Elicits Effective Antitumor Immunity against Spontaneously Arising Breast Tumors. | J Immunol | 2023 | 37256255 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8784/papers?page=26